Treatment with the BCL-2/BCL-xL inhibitor senolytic drug ABT263/Navitoclax improves functional hyperemia in aged mice
Stefano Tarantini, Priya Balasubramanian, Jordan DelFavero, Tamás Csípő, Andriy Yabluchanskiy, Tamás Kiss, Ádám Nyúl‐Tóth, Péter Mukli, Péter Tóth, Chetan Ahire, Anna Ungvari, Zoltán Benyó, Anna Csiszár, Zoltán Ungvári
Topics & Concepts
DrugPharmacologyMedicineChemistryDiabetes and associated disordersImmune cells in cancerSingle-cell and spatial transcriptomics